IL-22 levels are significantly elevated in AD patients and are a key factor in driving the inflammatory response, disrupting skin barrier function, and ultimately leading to the characteristic symptoms of AD (Laska et al., 2024). The gene discussed is IL22; the disease is Alzheimer disease.